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AbsTrACT
Objective The aim of this study was to monitor the 
activity and evaluate the clinical safety of a minor eye 
conditions scheme (MECS) conducted by accredited 
community optometrists in Lambeth and Lewisham, 
London.
Methods and analysis Optometrists underwent an 
accredited training programme, including attendance at 
hospital eye services (HES) clinics. Patients who satisfied 
certain inclusion criteria were referred to accredited MECS 
optometrists by their general practitioners (GPs) or could 
self-refer. Data were extracted from clinical records. A 
sample of MECS clinical records was graded to assess the 
quality of the MECS optometrists’ clinical management 
decisions. Referrals to the HES were assessed by the 
collaborating ophthalmologists and feedback was provided.
results A total of 2123 patients (mean age 47 years) 
were seen over 12 months. Two-thirds of the patients 
(67.3%) were referred by their GP. The most common 
reasons for patients needing a MECS assessment were 
‘red eye’ (36.7% of patients), ‘painful white eye’ (11.1%), 
‘flashes and floaters’ (10.2%); 8.7% of patients had a 
follow-up appointment. Of the patients seen, 75.1% 
were retained in the community, 5.7% were referred to 
their GP and 18.9% were referred to the HES. Of the HES 
referrals, 49.1% were routine, 22.6% urgent and 28.3% 
emergency. Of the records reviewed, 94.5% were rated as 
appropriately managed; 89.2% of the HES referrals were 
considered appropriate.
Conclusion The findings of this study indicate that 
optometrists are in a good position to work very safely 
within the remits of the scheme and to assess risk.
InTrOduCTIOn
Over the last decade, there has been a 
40% increase in eye-related hospital visits 
across the UK and ophthalmology currently 
accounts for approximately 10% of all 
National Health Service (NHS) outpatient 
attendances.1–3 In addition to the burden 
associated with chronic eye disease, there is 
an escalating problem delivering emergency 
eye care services. For example, the number 
of patients attending the two largest emer-
gency eye units in London is increasing by 
7.9% and 9.6% per year.4 There is growing 
recognition that rising demands on eye care 
services may result in delays and poorer visual 
outcomes for those waiting for treatment 
or disease monitoring.5 6 There is an urgent 
need to manage the flow of patients between 
primary and secondary care and evaluate 
emerging technology to facilitate clinical 
decision-making to ensure that patients are 
seen by the most appropriate healthcare 
professional, in the most appropriate setting, 
and in a timely manner to minimise the likeli-
hood of visual loss.
In the UK, ophthalmic care is primarily 
provided by community optometrists, general 
practitioners (GPs), community pharmacy 
and the Hospital Eye Service (HES). Optom-
etrists provide primary ophthalmic care 
and sight tests. GPs also provide primary 
ophthalmic care as patients often present to 
their GP with an eye-related problem which 
has the potential to be managed by their 
optometrist. The HES provides secondary 
ophthalmic care either via outpatient clinics 
or at an accident and emergency (A&E) level; 
Key messages
What is already known about this subject?
 ► Rising demands on eye care services may result in 
delays and poorer visual outcomes for those waiting 
for treatment. Despite the widespread adoption of 
optometric Enhanced Service Schemes (ESS) across 
the UK, there is a lack of information on clinical 
safety, patient satisfaction and cost effectiveness.
What are the new findings?
 ► We report clinical safety data, demonstrating that 
community optometrists can assess and manage 
patients safely, within the remits of optometric ESS.
How might these results change the focus of 
research or clinical practice?
 ► Ophthalmologist and general  practitioner 
collaboration with the optometrist is desirable for the 
development of safe and efficient optometric ESS 
that will operate under a robust clinical governance 
framework.
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although the latter has been designed for secondary care 
provision, it is increasingly used for primary care. Up 
to 70% of ophthalmic A&E cases could be managed in 
the community (eg, a community optometrist)7–11; addi-
tionally, many of the patients attending ophthalmic A&E 
departments are discharged without the need for a subse-
quent outpatient appointment.12 Optometrists have been 
considered responsible for most routine ophthalmic 
referrals to the HES13 14; it was, however, recently shown 
that the majority of walk-ins to a London specialised 
ophthalmic A&E department self-refer, very often for 
‘convenience’.4 7
In an effort to ease overstretched HES resources, a 
number of enhanced service schemes (ESSs) have been 
introduced in the UK. These schemes aim to refine 
HES referrals via either confirming the necessity of the 
referral or managing the patient in a community setting. 
A number of minor/anterior eye condition schemes 
have been launched in the UK, which aim to reduce 
A&E workload, assist GPs and increase patients’ acces-
sibility to specialist professional equipment and skills.15 
Despite their widespread adoption across the UK, there is 
a dearth of formal evaluation of ESSs in terms of clinical 
safety, patient satisfaction and cost effectiveness. Subse-
quently, the safety and generalisability of the schemes 
remains unknown. The aim of this study was to monitor 
the activity and evaluate the clinical safety of a minor eye 
conditions scheme (MECS) in Lambeth and Lewisham, 
London. Patient satisfaction and cost effectiveness of the 
scheme have been reported elsewhere.16–18
MeTHOds
The MeCs
The scheme has been previously described elsewhere.19 
In brief, the scheme was launched in April 2013 using 
10 optometrists based in 13 community optometric 
practices. Participating optometrists were appropriately 
trained and accredited and a further requirement was 
that they should be successful in an assessment of key 
clinical skills via a practical station examination. Optom-
etrists were not required to obtain a specialist prescribing 
qualification, but were permitted to supply certain medi-
cations according to the Medicines Act exemptions 
legislation.20 Additionally, optometrists were required to 
observe in HES clinics and they maintained contact, on a 
scheduled basis, with two consultant ophthalmologists at 
either King’s College Hospital or Guy’s and St Thomas’s 
Hospital; both ophthalmologists were also participants in 
MECS. Each ophthalmologist had one allocated MECS 
clinical session per week, with a remit to review clinical 
records of patients referred to the HES via the scheme. 
In addition, the ophthalmologists delivered ongoing 
mentoring and continuing education to the optometrists 
involved in the scheme.
Those patients who attended their GP practice with 
symptoms of red eye, loss of vision, trauma, headaches, 
painful white eye, and flashes and floaters were referred 
to the scheme’s optometrists. Alternatively, patients could 
self-refer to any optometrist accredited to MECS. After 
the MECS assessment, which took place within 48 hours, 
patients were either managed within the optometric prac-
tice or referred to the HES; a further option for patients 
was a referral to their GP for systemic investigations.
scheme activity and data collection
For the current study, a period of 12 calendar months 
from September 2013 to August 2014 was chosen and 
data were collected from all patients examined in MECS 
during that period, who gave informed consent for 
collection of their fully anonymised clinical data. Each 
patient’s age, first part of postcode, ethnicity, GP details, 
presenting complaint, vision and/or visual acuity, diag-
nosis, management and, where applicable, the HES to 
which that referral was made, the urgency of referral and 
the HES diagnosis were extracted from clinical records 
and entered onto a secure database.
Referrals to the collaborating HES (Guy’s and St Thom-
as’s Hospital and King’s College Hospital) were assessed 
by participating ophthalmologists; the research team 
had access to the diagnosis made in the HES for referred 
patients, and these diagnoses were compared with those 
made by the MECS optometrists. The HES ophthalmolo-
gists provided feedback on how appropriate each referral 
was and whether each referral was made with appropriate 
urgency. The International Classification of Diseases 
codes by WHO21 was employed to record each patient’s 
diagnosis, whether this was made in the community, in 
the HES or in both locations.
Clinical safety
A random sample of 44 clinical records of patients 
examined in MECS optometric practices were initially 
assessed by all four members of the research team, and 
good agreement on the practitioners’ patient manage-
ment of each case was established using multiple kappa 
values. A randomly selected sample of 220 MECS clinical 
records (stratified by practitioner), comprising approxi-
mately 10% of all records of patients seen through MECS 
during the study period, was then reviewed and inde-
pendently graded by four members of the research team. 
Since agreement among the members of the research 
team had been established, the records were randomly 
assigned to four equal-sized groups, and each group of 
records was reviewed by one grader. Records were made 
available via http://www. dropbox. com, and a recording 
sheet for each grader was made available on http://www. 
surveymonkey. com. The College of Optometrists Clinical 
Management Guidelines22 and the PEARS guidelines on 
flashes and floaters, produced by Optometry Wales and 
the Wales Optometry Postgraduate Education Centre 
(WOPEC),23 were used by the graders as reference mate-
rial, which allowed them to assess the quality of the MECS 
optometrists’ clinical management for each patient 
record reviewed. The above guidelines had been made 
available to the participating community optometrists 
during their training.
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The researchers reviewed each record independently 
and graded MECS optometrists’ clinical care for each 
patient as either ‘appropriate’ or ‘inappropriate’. A 
grading of appropriate care was given when the optom-
etrist’s assessment and management of the patient was 
completely or substantially in accordance with the refer-
ence guidelines or when management, although deficient 
in some aspects of care proposed in the guidelines, was 
regarded as carrying no risk to patient safety. Patient care 
was graded as inappropriate where the optometrist had 
assessed and/or managed the patient in a way that was 
inappropriate based on the reference guidelines and/or 
was regarded as unsafe. In cases where patient care was 
deemed ‘inappropriate’, the reviewing optometrist gave 
the rationale for their decision by choosing one or more 
of the following options: prescription error, inappro-
priate non-referral, inappropriate referral, inappropriate 
referral urgency, inappropriate discharge and/or other. 
All ‘inappropriate’ ratings were reviewed by all members 
of the research team through a consensus meeting.
Referrals to the HES were assessed by ophthalmolo-
gists working in the affiliated hospitals. The diagnoses by 
HES clinicians were made available to the research team 
and were cross-referenced with MECS optometrists’ diag-
noses. HES ophthalmologists also provided feedback on 
referral appropriateness and referral urgency appropri-
ateness.
statistical analysis
The SPSS software (IBM, released 2013. IBM SPSS Statis-
tics for Windows, V. 22.0) was used to calculate Cohen’s 
kappa for agreement between the research optometrists 
assessing clinical safety; P<0.05 was taken to be statisti-
cally significant.
resulTs
scheme activity
In the course of the 12-month monitoring period, a 
total of 2123 patients were assessed by 10 community 
optometrists in 13 practices, in 2307 visits. The age range 
of patients presenting to MECS was from 1 to 93 years 
(mean age 47 years, SD=19 years, the age data were 
normally distributed). People of all ethnicities residing 
in Lambeth and Lewisham had access to the scheme, and 
patients accessing the scheme had a similar ethnic distri-
bution to that of the two Boroughs.24 25
The proportion of patients entering MECS via a GP 
referral was around two-thirds of the total (67.3%, 
n=1429); self-referral accounted for 568 patients 
(26.8%), pharmacist referrals totalled 2.2% and a 
further 3.4% converted to a MECS appointment from 
a standard GOS sight test. The most common reasons 
for patients needing a MECS assessment were ‘red eye’ 
(36.7%, n=777), ‘painful white eye’ (11.1%, n=236), 
‘flashes and floaters’ (10.2%, n=216) and ‘loss of vision’ 
(9.2%, n=194). Less frequently reported reasons were 
‘headaches’ (5.3%, n=112), ‘trauma’ (1.7%, n=36) and 
‘diplopia’ (0.4%, n=8). Approximately one MECS patient 
in four (25.4%, n=538) presented with a reason which was 
not in the predefined categories; more than two-thirds of 
these (69.1%, n=372) presented with symptoms related 
to the anterior eye (table 1). A total of 184 patients 
(8.7%) re-presented to their MECS optometric practice 
for a follow-up examination, predominantly following up 
minor trauma (22.2%, n=8, of patients initially presenting 
with trauma), diplopia (12.5%, n=1, of patients initially 
presenting with diplopia) and red eye (11.5%, n=89, of 
patients initially presenting with red eye).
Approximately three quarters of MECS patients (75.1%, 
n=1595) remained within community optometric prac-
tice; 64.0% (n=1359) were diagnosed with pathology 
managed in the community and in 11.1% of cases 
(n=236) the optometrist detected no ocular pathology 
and the patient was therefore discharged. In total, 5.7% 
of the patients (n=122) were referred to their GP and 
in 18.9% of cases (n=400) the examination resulted in 
referral to the HES (table 2). Of HES referrals 49.1% 
were routine, 22.6% urgent and 28.3% emergency.
Table 1 Reasons for minor eye conditions scheme (MECS) 
visits 
Reason for MECS visit Patients, n (%)
Red eye 777 (36.7)
Painful white eye 236 (11.1)
Flashes and floaters 216 (10.2)
Loss of vision 194 (9.2)
Headaches 112 (5.3)
Trauma 36 (1.7)
Diplopia 8 (0.4)
Other 538 (25.4)
  Swollen lid/lid lump 122 (22.7)
  Watery eyes 111 (20.6)
  Foreign body sensation, sore/
dry/gritty eyes 
83 (15.4)
  Itchy eyes 56 (10.4)
The reason for the MECS visit was not recorded for six patients. 
Table 2 Management of patients seen within minor eye 
conditions scheme (MECS)
MECS visit outcome Patients, n (%)
Retained in optometric practice 1595 (75.1)
  Management of ocular pathology in 
practice
1359 (64.0)
  No ocular pathology—discharged 236 (11.1)
Referral to King’s College Hospital 220 (10.4)
Referral to Guy’s and St Thomas’s 
Hospital
154 (7.3)
Referral to other hospital eye services 26 (1.2)
Referral to general practitioner 122 (5.7)
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Presenting complaints most commonly managed in 
practice were red eyes (79.3%, n=616), painful white eye 
(64.4%, n=152), flashes/floaters (61.6%, n=133) and 
trauma (63.9%, n=23) (table 3). Patients presenting with 
headaches were most commonly discharged without any 
pathology being identified (51.8%, n=58) or referred to 
the GP for further investigations (26.8%, n=30). A total 
of 22.7% of patients discharged without an identified 
pathology had an uncorrected refractive error causing 
the presenting symptoms.
Community optometrists referred patients to their 
GP for lid neoplasms, dermatitis, migraines, investiga-
tion of blood pressure, amaurosis fugax and trigeminal 
neuralgia. Optometrists also referred patients to their GP 
for the prescription of oral antibiotics.
The presenting complaint that resulted in the 
greatest proportion of patients being referred to 
the HES was diplopia (n=8; 75% referred to HES), 
followed by loss of vision (n=194; 51.0% referred) 
and flashes and/or floaters (n=216; 25.9% referred). 
Of the 216 patients presenting with flashes/floaters, 
72.2% (n=156) were either managed in practice (with 
diagnoses of posterior vitreous detachment, vitreous 
floaters/syneresis or ocular migraine) or discharged 
with no obvious ocular pathology, and approximately 
a quarter (25.9%, n=56) of patients were referred 
to the HES. Of the 56 patients referred to the HES 
due to flashes and floaters, no information of the 
referral urgency was recorded for two patients. Of 
the remaining 54 patients, 37.0% (n=20) were 
referred as an emergency (provisional diagnoses: 
PVD, retinal breaks, retinal hole, retinal vascular 
occlusions or macular haemorrhage), 27.8% (n=15) 
urgently (PVD or peripheral retinal haemorrhages) 
and 35.2% (n=19) routinely (PVD only); 1.4% (n=3) 
of those presenting with flashes and/or floaters were 
referred to their GP for investigation of migraine.
The main pathologies managed in optometric 
practice were related to the eyelid, lacrimal system, 
orbit, conjunctiva, cornea, sclera and the vitreous 
(based on the optometrists’ provisional diagnoses) 
(table 4). The provisional diagnoses that most 
commonly led to a HES referral were disorders of 
the retina (macular pathologies, retinal vascular 
pathologies and suspect retinal tears/detachments), 
corneal ulcers, keratitis, eyelid disorders (chal-
azia warranting excision, entropion/ectropion and 
stenosis of the lacrimal passages), glaucoma, uveitis 
and visual pathway disorders.
Table 4 Management of the patients based on the 
optometrists’ provisional diagnosis, categorised by the 
International Classification of Diseases codes by WHO
Optometrists’ provisional 
diagnosis
Patients 
retained in the 
community*, n 
(%)
Patients 
referred to 
HES , n (%)
Eyelid, lacrimal system, orbit 335 (81.3) 60 (14.6)
Diseases of the conjunctiva 357 (87.5) 19 (4.7)
Disorders of the cornea and 
sclera
443 (82.6) 74 (13.8)
Disorders of the iris and ciliary 
body
1 (3.4) 27 (93.1)
Disorders of the lens 23 (60.0) 18 (40.0)
Disorders of choroid and retina 6 (6.3) 87 (90.6)
Glaucoma 4 (10.5) 33 (86.8)
Disorders of vitreous body and 
globe
117 (82.4) 25 (17.6)
Disorders of optic nerve and 
visual pathway
0 (0.0) 6 (100.0)
Disorders of ocular muscles, 
binocular movement, 
accommodation and refraction
55 (87.3) 7 (11.1)
Visual disturbances 35 (60.3) 14 (24.1)
Patients referred to the general practitioner are not shown in this 
table. For a total of 285 patients, no WHO disease code was 
applicable to the diagnosis.
* Patients managed in optometric practice or discharged without 
a pathology. 
Table 3 Management of the patients after the first minor eye conditions scheme (MECS) visit
Reason for MECS visit
Patients managed by the 
community optometrist, n 
(%)
Patients with no ocular 
pathology identified, n 
(%)
Patients referred to the 
hospital eye services, n 
(%)
Patients referred to 
general practitioner, 
n (%)
Red eye* 616 (79.3) 10 (1.3) 114 (14.7) 35 (4.5)
Painful white eye 152 (64.4) 37 (15.7) 33 (14.0) 14 (5.9)
Flashes/floaters† 133 (61.6) 23 (10.6) 56 (25.9) 3 (1.4)
Loss of vision† 44 (22.7) 41 (21.1) 99 (51.0) 9 (4.6)
Headaches 13 (11.6) 58 (51.8) 11 (9.8) 30 (26.8)
Trauma 23 (63.9) 10 (27.8) 3 (8.3) 0 (0.0)
Diplopia 1 (12.5) 0 (0.0) 6 (75.0) 1 (12.5)
Other† 375 (69.7) 56 (10.4) 76 (14.1) 30 (5.6)
*Information was not available for two patients in this category.
†Information was not available for one patient in this category.
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Prescription of medication
Medication was supplied to 48.3% (n=1025) of MECS 
patients. Ocular lubricants were most commonly supplied 
(29.7% of all patients seen through MECS, n=630), 
followed by topical antibiotic drops (ie, chloramphen-
icol or fusidic acid, 12.1%, n=257), topical and systemic 
antiallergy agents (6.1%, n=129) and systemic analgesia 
(0.5%, n=10).
Clinical safety
Overall agreement between the graders assessed on a 
sample of 44 records was ‘almost perfect’ according to 
the Landis-Koch criteria (average kappa=0.92, range 
0.87–0.97). Of the 220 records subsequently reviewed, 
5.5% (n=12) were rated as inappropriate. Details of those 
cases where the assessment/management was rated as 
inappropriate are listed in table 5; in the opinion of the 
graders, three of the patients whose management was 
rated as inappropriate could have come to harm by the 
optometrists’ management (1.36% of all patient records 
reviewed).
Collaborating ophthalmologists from KCH and GST 
reviewed 72.0% of the HES referrals (either community 
optometrists’ referral letters and clinical notes or HES 
clinical records). Of these, 89.2% were judged to have 
been appropriately referred and 78.2% were referred 
with appropriate urgency. For 59.7% of the HES refer-
rals, feedback was provided after an ophthalmologist 
reviewed the HES records and included diagnosis by a 
HES ophthalmologist, management and a judgement on 
the appropriateness of referral and referral urgency. Of 
these 87.9% had been appropriately referred according 
to an ophthalmologist. Inappropriate referrals (ie, 
unnecessary referrals to the HES) were related to long-
standing corneal scars, anisocoria, PVD, refractive error, 
blepharitis, chalazia, conjunctivitis, macular degen-
eration, long-standing toxoplasmosis scars, refractive 
error and functional vision loss (online supplementary 
appendix 1). Of the appropriate HES referrals, 70% 
were made with appropriate urgency; 28.3% of referrals 
were referred more urgently than necessary; 1.7% (n=4) 
of all referrals were made with a lower urgency than 
appropriate; these referrals were related to a corneal 
foreign body, scleritis and PVD (online supplementary 
appendix 2).
dIsCussIOn
The Lambeth and Lewisham MECS was designed to 
reduce ophthalmology referrals in the two London 
boroughs, after an earlier audit by Lambeth CCG indi-
cated that approximately 38% of acute ophthalmology 
referrals could have been managed in a community 
setting, for example, by a community optometrist or by the 
GP.26 This finding is consistent with an audit of cases seen 
in a dedicated ophthalmic A&E department in central 
London.7 The pilot Lambeth and Lewisham MECS was 
supported by a robust clinical governance framework, 
where structured training was required for optometrists' 
participation. Participating community optometrists 
had access to specially designed training (LOCSU and 
WOPEC), evidence-based clinical management guide-
lines freely provided by the College of Optometrists,22 
attended A&E sessions at their local HES and main-
tained scheduled contact with participating consultant 
ophthalmologists, who also provided feedback on HES 
referrals. Participating community optometrists were 
permitted to exercise clinical judgement, as it has been 
shown that participation in ESS provides an exposure to 
more challenging clinical cases, allowing optometrists 
Table 5 Details of the patients’ management rated as inappropriate by the research team
Optometrists’ diagnosis Reason for inappropriate rating
Corneal abrasion Inappropriate patching*†
Seasonal allergic conjunctivitis Unnecessary referral to GP
Recurrent painful white eye Unnecessary referral to HES
Viral conjunctivitis Unnecessary referral to HES
Bacterial conjunctivitis Unnecessary referral to GP
Possible CL-related infection Inappropriate treatment with chloramphenicol
Uncertain Prescription error (mast-cell stabiliser and antihistamine)
Allergic reaction and stye Inappropriate treatment with chloramphenicol and sodium cromoglycate
Recurring allergic conjunctivitis No attempt to try antihistamines or mast-cell stabilisers prior to referring to GP, no 
IOP measurement prior to suggesting steroid drops to be prescribed by the GP*‡
Macular RPE changes Inappropriate urgency for HES referral
Glaucoma suspect Inappropriate urgency for HES referral
Single floater No dilation, no checking for Schaeffer’s sign*‡
*The patient could have come to harm due to the optometrists’ management.
†The patient returned to the practice, and it was confirmed that the abrasion had healed without any complications.
‡The final outcome of these cases could not be established.
CL, contact lens; GP, general practitioner; HES, hospital eye services; IOP, intraocular pressure; RPE, retinal pigment epithelium.
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to use clinical skills to a greater extent. Local CCGs, 
collaborating hospitals and the Eye Group (comprising 
commissioners, GPs, ophthalmologists and optometrists) 
met on a regular basis to discuss the activity and overall 
usefulness of the scheme.
A total of 2123 patients drawn from a wide range of 
ethnic groups used the scheme within the first year; and 
67.3% of these patients were referred from their GP. 
Previous research supports the finding that GPs favour 
assessment of patients presenting with ophthalmic 
complaints by optometrists (especially in cases that 
would be hard to diagnose by GPs, eg, red eyes, flashes 
and floaters)16 27 and highlights the value of specialist 
tools (slit-lamp biomicroscopy, fundoscopy) in the diag-
nosis and management of commonly presenting ocular 
pathologies. More than 80% of the patients that were 
diagnosed with anterior eye conditions, binocular vision 
disturbances, vitreous pathologies and ocular migraines 
were retained in the community and appropriately 
managed by the optometrists; a large proportion (60%) 
of patients diagnosed with cataracts were also retained in 
the community.
The above pathologies have independently been 
shown to be satisfactorily managed by community 
services.7 The optometrists’ specialist knowledge of eye 
pathology, as well as the use of dedicated ESS appoint-
ments, has allowed optometrists to tailor their clinical 
assessment to patients’ needs and thoroughly discuss 
management options. The findings of this study indicate 
that optometrists are in a good position to differentiate 
between various ocular pathologies and to assess risk; the 
vast majority of choroid, visual pathway and optic nerve 
pathologies were referred to the HES, indicating that the 
participating community optometrists understand the 
limitations of an ESS and a MECS specifically.
The appropriateness of HES referrals via MECS was 
better in this study compared with previously published 
data.28 A total of 95% of the patients seen within the 
scheme were assessed as being appropriately managed, 
with no clinical safety concerns. The management of 
patients in this ESS was shown to be safe, through a 
method involving research team consensus and ophthal-
mology evaluation of referrals. According to the HES 
consultant ophthalmologists, approximately 11% of 
referrals were judged unnecessary by ophthalmologists 
who monitored the scheme. Referrals were generally sent 
with an appropriate degree of urgency. Of those judged 
to be inappropriate, >90% were sent with greater urgency 
than considered necessary. These findings indicate a clin-
ically safe service, despite some differences of opinion 
between optometrists and ophthalmologists regarding 
referral urgency. These differences may be related, not 
only to training and clinical experience, but arguably 
also to knowledge of the evolving treatment options for 
certain pathologies.
A number of ESSs have been developed over the last 
decade; the PEARS scheme in Wales is similar to this 
MECS. Comparison with previous schemes will allow 
improvement of the services provided to patients and 
estimates of the cost savings to the NHS. A total of 75.1% 
of patients were retained in community optometric prac-
tices (either managed by community optometrists or 
discharged) compared with 66% of patients who accessed 
the Wales PEARS28 or other smaller schemes.29 30 A total 
of 8.7% of patients returned to community optometric 
practice for a follow-up appointment; this figure is lower 
than the average follow-up rate in similar ESS schemes 
which has been reported to be 22.13%,31 although some 
schemes have reported follow-up rates comparable to the 
Lambeth and Lewisham MECS.29 30 32 The vast majority 
of patients followed up by community optometrists had 
symptoms relating to the anterior eye, minor trauma or 
uncorrected refractive errors. Referral rates to GPs in the 
Lambeth and Lewisham MECS (5.7%) were also below 
the reported UK average for similar schemes (8.63%)31 
and lower than in the PEARS scheme (16%).28 HES 
referral rates for other MECS schemes in the UK have 
been reported to average 19.3%.31 Approximately 18.9% 
of patients accessing the Lambeth and Lewisham MECS 
were referred to the HES, a rate similar to the PEARS 
scheme (18.2%).
The MECS community optometrists supplied thera-
peutic agents to 48.3% in first and follow-up visits, despite 
a lack of non-medical prescribing qualification. Medica-
tion was supplied using a ‘signed order’ that could be 
presented to the pharmacist. A system was established 
for patients exempt from NHS prescription charges to 
allow pharmacies to provide medication free of charge. 
Ocular lubricants were the most commonly prescribed 
ocular medication, with approximately one quarter of 
patients issued a prescription being prescribed antibiotic 
drops. These interventions represent medications that 
can freely be prescribed by optometrists under the Entry 
Level Medicines Act exemptions.20
Ophthalmologists’ collaboration has been a key factor 
in the development of this pilot ESS, providing mento-
ring to community optometrists and feedback on referral 
safety. The scheme also benefited from a high level of GP 
engagement, with approximately two-thirds of patients 
being referred into MECS by local GPs. This study did 
not follow the principles of randomised controlled trials 
since an observational pragmatic evaluation is more suit-
able for community healthcare services research.33 The 
Lambeth and Lewisham MECS is one of the first ESS to 
be comprehensively evaluated; results suggest that the 
scheme is safe for patients, while providing a service 
that also benefits the NHS.18 Collaboration between eye 
care providers has promoted the scheme’s popularity 
and increased its chances of sustainability. Appropriate 
training, support by local CCGs and ongoing collabora-
tion between eye care providers are necessary to design 
and operate safe and successful ESSs that reduce hospital 
attendances.
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